Full-Time
Updated on 8/1/2026
End-to-end medical cannabis platform
€55k - €60k/yr
Remote in Germany
Hybrid
Remote within Germany, with regular customer visits and field-based events.
See people who can refer or advise you
Montu is a health technology company focusing on Australia’s medical cannabis sector. It runs a vertically integrated system that covers the entire patient journey from telehealth consultations to medication delivery, including the Alternaleaf telehealth clinic, Leafio distribution, uMeds fulfillment, and its own portfolio of cannabis products. Alternaleaf connects patients with a large network of doctors and nurses for online consultations, after which a prescription can be issued and Montu handles the downstream supply chain to deliver the medicine. The company earns revenue from telehealth visits and product sales, and it differentiates itself through its integrated platform that combines production, prescription, and dispensing, though this model has drawn regulatory scrutiny. Montu’s goal is to expand access to medical cannabis in Australia and grow its platform and product offerings within the healthtech cannabis market.
Company Size
501-1,000
Company Stage
Early VC
Total Funding
$3.6M
Headquarters
Santiago, Chile
Founded
2019
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Paid Vacation
401(k) Company Match
401(k) Retirement Plan
Cycle to work scheme
Montu has named former Pharmacy Guild of Australia national president George Tambassis as a special adviser.
Montu is launching online clinic Alternaleaf in the UK, headed up by local managing director Asif Dewan.
Montu has joined forces with Chronic Pain Australia (CPA) to promote Pain Awareness Month in a bid to raise A$100,000 for the cause.
We are Montu. Our mission: Improve lives for millions of Australians through medical cannabis therapies.
Montu will use the funds to boost its marketing and attract more doctors on to the platform to service patients who need cannabidiol-related treatments.